{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:49:40Z","timestamp":1785250180976,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ucl.2015.06.004","type":"journal-article","created":{"date-parts":[[2015,10,18]],"date-time":"2015-10-18T21:22:20Z","timestamp":1445203340000},"page":"507-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Sexually Transmitted Infections"],"prefix":"10.1016","volume":"42","author":[{"given":"Lindsay","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Angarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2015.06.004_bib1","series-title":"Sexually transmitted infections surveillance 2013","author":"Centers for Disease Control and Prevention","year":"2014"},{"issue":"Suppl 2","key":"10.1016\/j.ucl.2015.06.004_bib2","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1093\/infdis\/174.Supplement_2.S127","article-title":"Overview: individual and population approaches to the epidemiology and prevention of sexually transmitted diseases and human immunodeficiency virus infection","volume":"174","author":"Aral","year":"1996","journal-title":"J\u00a0Infect Dis"},{"issue":"RR-12","key":"10.1016\/j.ucl.2015.06.004_bib3","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2010","volume":"59","author":"Workowski","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"10.1016\/j.ucl.2015.06.004_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-153-1-201007060-00003","article-title":"Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data","volume":"153","author":"Jena","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ucl.2015.06.004_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-158-6-201303190-00005","article-title":"GeoSentinel surveillance of illness in returned travelers, 2007\u20132011","volume":"158","author":"Leder","year":"2013","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ucl.2015.06.004_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.7326\/0003-4819-149-7-200810070-00010","article-title":"Behavioral counseling to prevent sexually transmitted infections: U.S. Preventive Services Task Force recommendation statement","volume":"149","author":"U.S. Preventive Services Task Force","year":"2008","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.ucl.2015.06.004_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.7326\/0003-4819-149-7-200810070-00011","article-title":"Behavioral counseling to prevent sexually transmitted infections: a systematic review for the U.S. Preventive Services Task Force","volume":"149","author":"Lin","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.ucl.2015.06.004_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1201-9712(98)90088-1","article-title":"Herpes simplex type II and Mycoplasma genitalium as risk factors for heterosexual HIV transmission: report from the heterosexual HIV transmission study","volume":"3","author":"Perez","year":"1998","journal-title":"Int J Infect Dis"},{"issue":"9","key":"10.1016\/j.ucl.2015.06.004_bib9","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4065\/82.9.1091","article-title":"Syphilis in the United States: an update for clinicians with an emphasis on HIV coinfection","volume":"82","author":"Zetola","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.ucl.2015.06.004_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1086\/381227","article-title":"Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features","volume":"189","author":"Marra","year":"2004","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.ucl.2015.06.004_bib11","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1086\/500406","article-title":"Doxycycline compared with benzathine penicillin for the treatment of early syphilis","volume":"42","author":"Ghanem","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.ucl.2015.06.004_bib12","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1001\/jama.296.8.964","article-title":"Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States","volume":"296","author":"Xu","year":"2006","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ucl.2015.06.004_bib13","doi-asserted-by":"crossref","first-page":"958","DOI":"10.7326\/0003-4819-98-6-958","article-title":"Genital herpes simplex virus infections: clinical manifestations, course, and complications","volume":"98","author":"Corey","year":"1983","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ucl.2015.06.004_bib14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1086\/380838","article-title":"Etiology of clinical proctitis among men who have sex with men","volume":"38","author":"Klausner","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ucl.2015.06.004_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/sti.78.3.160","article-title":"Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision","volume":"78","author":"Scoular","year":"2002","journal-title":"Sex Transm Infect"},{"issue":"7466","key":"10.1016\/j.ucl.2015.06.004_bib16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/bmj.329.7466.618","article-title":"Ethics of screening for asymptomatic herpes virus type 2 infection","volume":"329","author":"Krantz","year":"2004","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.ucl.2015.06.004_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/sti.79.1.68","article-title":"Chancroid: clinical manifestations, diagnosis, and management","volume":"79","author":"Lewis","year":"2003","journal-title":"Sex Transm Infect"},{"issue":"Suppl 4","key":"10.1016\/j.ucl.2015.06.004_bib18","first-page":"iv19","article-title":"Chancroid","volume":"82","author":"Lewis","year":"2006","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ucl.2015.06.004_bib19","article-title":"Acute epididymitis revisited: impact of molecular diagnostics on etiology and contemporary guideline recommendations","author":"Pilatz","year":"2014","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2015.06.004_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ucl.2007.09.013","article-title":"Diagnosis and management of epididymitis","volume":"35","author":"Tracy","year":"2008","journal-title":"Urol Clin North Am"},{"issue":"2","key":"10.1016\/j.ucl.2015.06.004_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-147-2-200707170-00172","article-title":"Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement","volume":"147","author":"U.S. Preventive Services Task Force","year":"2007","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ucl.2015.06.004_bib22","first-page":"819","article-title":"USPSTF recommendations for STI screening","volume":"77","author":"Meyers","year":"2008","journal-title":"Am Fam Physician"},{"issue":"3","key":"10.1016\/j.ucl.2015.06.004_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1370\/afm.337","article-title":"Screening for gonorrhea: recommendation statement","volume":"3","author":"U.S. Preventive Services Task Force","year":"2005","journal-title":"Ann Fam Med"},{"issue":"31","key":"10.1016\/j.ucl.2015.06.004_bib24","first-page":"590","article-title":"Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.ucl.2015.06.004_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.2012.205107","article-title":"Cephalosporin-resistant gonorrhea in North America","volume":"309","author":"Kirkcaldy","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ucl.2015.06.004_bib26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1086\/499434","article-title":"Etiologies of nongonococcal urethritis: bacteria, viruses, and the association with orogenital exposure","volume":"193","author":"Bradshaw","year":"2006","journal-title":"J\u00a0Infect Dis"},{"issue":"11","key":"10.1016\/j.ucl.2015.06.004_bib27","doi-asserted-by":"crossref","first-page":"e3618","DOI":"10.1371\/journal.pone.0003618","article-title":"Persistence of Mycoplasma genitalium following azithromycin therapy","volume":"3","author":"Bradshaw","year":"2008","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ucl.2015.06.004_bib28","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.297.8.813","article-title":"Prevalence of HPV infection among females in the United States","volume":"297","author":"Dunne","year":"2007","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ucl.2015.06.004_bib29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/oxfordjournals.aje.a010166","article-title":"Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis","volume":"151","author":"Myers","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"7","key":"10.1016\/j.ucl.2015.06.004_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ucl.2015.06.004_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"5A","key":"10.1016\/j.ucl.2015.06.004_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9343(97)00177-0","article-title":"Epidemiology of genital human papillomavirus infection","volume":"102","author":"Koutsky","year":"1997","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ucl.2015.06.004_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ogc.2013.03.003","article-title":"Vulvar and vaginal HPV disease","volume":"40","author":"Nelson","year":"2013","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"7","key":"10.1016\/j.ucl.2015.06.004_bib34","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-148-7-200804010-00004","article-title":"Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003\u20132005","volume":"148","author":"Datta","year":"2008","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.ucl.2015.06.004_bib35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.AOG.0000187301.76283.7f","article-title":"Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women","volume":"106","author":"Jones","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.ucl.2015.06.004_bib36","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ucl.2015.06.004_bib37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/00003495-199958020-00017","article-title":"Topical imiquimod: a review of its use in genital warts","volume":"58","author":"Perry","year":"1999","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ucl.2015.06.004_bib38","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0002-9343(94)90168-6","article-title":"Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts","volume":"96","author":"Bonnez","year":"1994","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ucl.2015.06.004_bib39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1086\/517472","article-title":"A\u00a0randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod","volume":"178","author":"Tyring","year":"1998","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.ucl.2015.06.004_bib40","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1258\/095646206777689161","article-title":"An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women","volume":"17","author":"Garland","year":"2006","journal-title":"Int J STD AIDS"},{"issue":"4","key":"10.1016\/j.ucl.2015.06.004_bib41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/OLQ.0b013e31815ea8d1","article-title":"Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis","volume":"35","author":"Gotovtseva","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"1","key":"10.1016\/j.ucl.2015.06.004_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.ucl.2015.06.004_bib43","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-2133.2008.08520.x","article-title":"Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial","volume":"158","author":"Stockfleth","year":"2008","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.ucl.2015.06.004_bib44","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/AOG.0b013e3181719b60","article-title":"Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial","volume":"111","author":"Tatti","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ucl.2015.06.004_bib45","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/j.1468-3083.2012.04493.x","article-title":"2012 European guideline for the management of anogenital warts","volume":"27","author":"Lacey","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.ucl.2015.06.004_bib46","first-page":"905","article-title":"ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus","volume":"105","author":"American College of Obstetricians and Gynecologists","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ucl.2015.06.004_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0042-6822(91)90772-4","article-title":"Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles","volume":"185","author":"Zhou","year":"1991","journal-title":"Virology"},{"issue":"19","key":"10.1016\/j.ucl.2015.06.004_bib48","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.ucl.2015.06.004_bib49","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","author":"FUTURE II Study Group","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"9686","key":"10.1016\/j.ucl.2015.06.004_bib50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of\u00a0human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ucl.2015.06.004_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.ucl.2015.06.004_bib52","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ucl.2015.06.004_bib53","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A\u00a09-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.ucl.2015.06.004_bib54","first-page":"300","article-title":"Use of 9-Valent Human Papillomavirus (HPV) Vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices","volume":"64","author":"Petrosky","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"10.1016\/j.ucl.2015.06.004_bib55","doi-asserted-by":"crossref","first-page":"894","DOI":"10.7326\/M14-1965","article-title":"Behavioral counseling interventions to prevent sexually transmitted infections: U.S. PreventiveServices Task Force recommendation statement","volume":"161","author":"LeFevre","year":"2014","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.ucl.2015.06.004_bib56","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7326\/M14-0475","article-title":"Behavioral sexual risk-reduction counseling in primary care to prevent sexually transmitted infections: a systematic review for the U.S. Preventive Services Task Force","volume":"161","author":"O'Connor","year":"2014","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1016\/j.ucl.2015.06.004_bib57","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2013.280035","article-title":"Eliminating prevention counseling to improve HIV screening","volume":"310","author":"Haukoos","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ucl.2015.06.004_bib58","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa041681","article-title":"Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection","volume":"352","author":"Golden","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ucl.2015.06.004_bib59","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1086\/432476","article-title":"Patient-delivered partner treatment for male urethritis: a randomized, controlled trial","volume":"41","author":"Kissinger","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.ucl.2015.06.004_bib60","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1086\/511429","article-title":"Partner notification for sexually transmitted diseases","volume":"44","author":"Hogben","year":"2007","journal-title":"Clin Infect Dis"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014315000567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014315000567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:27:53Z","timestamp":1758806873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014315000567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0094014315000567"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2015.06.004","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sexually Transmitted Infections","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2015.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}